Nickel-Catalyzed Antibody Bioconjugation
- 11 November 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 145 (47) , 25842-25849
Abstract
New biocompatible methods for post-translational protein modification are challenging to develop but crucial to create improved chemical probes and optimize next-generation biologic therapies such as antibody-drug conjugates (ADCs). Herein, we describe the bottom-up construction of an aqueous nickel-catalyzed cross-coupling for the chemospecific arylation of cysteine residues on peptides and proteins and its use for the preparation of ADCs. A variety of arene linkages are exemplified, enabling the incorporation of small molecules, probes, and cytotoxic payloads. The utility of this new bioconjugation platform in a drug discovery setting is highlighted by the construction of novel ADCs with target-mediated in vitro cytotoxic activity.Keywords
This publication has 61 references indexed in Scilit:
- Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer2014
- Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 ReceptorDrug Metabolism and Disposition, 2013
- The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imagingChemical Communications, 2013
- Bioactivation of 2-(Alkylthio)-1,3,4-Thiadiazoles and 2-(Alkylthio)-1,3-BenzothiazolesChemical Research in Toxicology, 2012
- A novel pathway for maytansinoid release from thioether linked antibody–drug conjugates (ADCs) under oxidative conditionsChemical Communications, 2011
- Contribution of Linker Stability to the Activities of Anticancer ImmunoconjugatesBioconjugate Chemistry, 2008
- Nickel Ion Complexes of Amino Acids and Peptides2007
- Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumoursBritish Journal of Cancer, 2006
- Repair of oxidative DNA damage by amino acidsNucleic Acids Research, 2003
- Some properties of diastereomers formed in the reactions of N-ethylmaleimide with biological thiols.Agricultural and Biological Chemistry, 1985